Lenalidomide as a novel treatment for refractory acquired von Willebrand syndrome associated with monoclonal gammopathy
- 1 June 2016
- journal article
- case report
- Published by Elsevier BV in Journal of Thrombosis and Haemostasis
- Vol. 14 (6), 1200-1205
- https://doi.org/10.1111/jth.13317
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Acquired von Willebrand Syndrome in Patients With a Centrifugal or Axial Continuous Flow Left Ventricular Assist DeviceJACC: Heart Failure, 2014
- Diagnosis and treatment of acquired von Willebrand syndromeThrombosis Research, 2012
- Acquired von Willebrand Syndrome Associated With Monoclonal GammopathyMedicine, 2011
- How I treat the acquired von Willebrand syndromeBlood, 2011
- Acquired von Willebrand Syndrome After Continuous-Flow Mechanical Device Support Contributes to a High Prevalence of Bleeding During Long-Term Support and at the Time of TransplantationJournal of the American College of Cardiology, 2010
- Diagnostic workup of patients with acquired von Willebrand syndrome: a retrospective single‐centre cohort studyJournal of Thrombosis and Haemostasis, 2008
- Acquired von Willebrand Syndrome in Aortic StenosisNew England Journal of Medicine, 2003
- Acquired von Willebrand Syndrome: Experience from 2 Years in a Single Laboratory Compared with Data from the Literature and an International RegistrySeminars in Thrombosis and Hemostasis, 2002
- Acquired von Willebrand Syndrome: Data from an International RegistryThrombosis and Haemostasis, 2000
- Comparison of inhibitory and binding characteristics of an antibody causing acquired von Willebrand syndrome: an assay for von Willebrand factor binding by antibodyBlood, 1985